Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks [Phase 2]
Phase 2 trial results for CP-690,550 (tofacitinib) as monotherapy at three dose levels versus placebo in rheumatoid arthritis; results were …
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis [Phase 1, Phase 2]
Clinical trial update reporting a multiple-dose study of ATN-103 in subjects with active rheumatoid arthritis, conducted in Phase 1/2, which…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan [Phase 2]
Phase 2 study in Japan evaluating four doses of tofacitinib (CP-690,550) versus placebo, each with methotrexate, for rheumatoid arthritis; r…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis [Phase 1]
This report covers a Phase 1 study by Pfizer examining the effect of tasocitinib (CP-690,550) on cholesterol metabolism in patients with act…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids [Phase 4]
Phase 4 trial aimed at improving bone health in rheumatoid arthritis patients on chronic glucocorticoids; the trial status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Remicade Infusion Management Program
This update reports completion of Janssen's Remicade infusion management program trial evaluating infliximab for Crohn's disease and rheumat…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing two doses of CP-690,550 (tofacitinib) against placebo in rheumatoid arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications [Phase 3]
Phase 3 trial comparing two doses of Xeljanz (tofacitinib) versus placebo in rheumatoid arthritis patients on background arthritis medicatio…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial of CP-690,550 (tofacitinib) vs placebo in rheumatoid arthritis patients with inadequate response to TNF inhibitors on backgrou…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis [Phase 3]
Phase 3 trial results compare two doses of CP-690,550 (tofacitinib) and the active comparator adalimumab (Humira) against placebo in rheumat…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate [Phase 3]
A two-year Phase 3 study of CP-690,550 (tofacitinib) in rheumatoid arthritis patients on background methotrexate completed; results were pos…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis [Phase 2]
Pfizer completed a Phase 2 trial to evaluate the mechanism of action of CP-690,550 (tofacitinib) in rheumatoid arthritis and posted the resu…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis [Phase 2]
Phase 2 trial comparing six doses of CP-690,550 (tofacitinib) plus methotrexate to placebo plus methotrexate in rheumatoid arthritis; result…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
This trial compares the safety and pharmacokinetics of Hanmi's HCP1004 with Vimovo (naproxen/esomeprazole) in healthy Korean male volunteers…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis [Phase 2]
Pfizer conducted a Phase 2 trial in patients diagnosed with rheumatoid arthritis; results were posted in January 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
This clinical trial update reports long-term safety data for tofacitinib (CP-690,550) in subjects with rheumatoid arthritis who participated…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating Revamilast in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan [Phase 2]
Pfizer-sponsored Phase 2 trial in Japan evaluating five doses of CP-690,550 (tofacitinib) vs placebo for rheumatoid arthritis has completed …
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Agility LP Ankle Arthroplasty Outcomes
A completed clinical trial assessing outcomes of the Agility LP ankle arthroplasty in patients with rheumatoid arthritis, osteoarthritis, an…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating the safety and efficacy of modified-release prednisone (Lodotra) for active rheumatoid arthritis has completed, wit…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial evaluating four doses of VX-509 in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550 [Phase 2]
Phase 2 trial assessing the effect of atorvastatin on cholesterol in patients with rheumatoid arthritis who are taking tofacitinib (CP-690,5…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients [Phase 3]
A Phase 3 trial evaluating the combination of tocilizumab with methotrexate for moderate-to-severe rheumatoid arthritis has completed.
-
FDA approval · 2012-12-12FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine En-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2012-12-10FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation.